26 Brands, 13 Companies: Mounjaro Takes A Hit As Affordable Semaglutide Copycats Rise
Last Updated:April 10, 2026, 10:57 IST Sales of injectable semaglutide units have surged nearly sixfold for March 2026 — based on just 10 days of sales, from March 21 to March 31. The entire GLP-1 agonist market in India stood at just Rs 113 crore in 2022. By March 2026, it had touched Rs 1,579…